Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...

The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

Investing.com -- China has approved GSK Plc ’s (LON:GSK) Nucala as an add-on maintenance treatment for adults with chronic ...

Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel ...

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

(Alliance News) - GSK PLC on Monday said mepolizumab, sold under the brand name Nucala, has been approved in China for use in adults with chronic obstructive pulmonary disease. The London-based ...

Just now, the U.S. House of Representatives passed a bipartisan bill which, if enacted, would extend the enhanced healthcare tax credits for three years. American Lung Association President and CEO Ha ...

A quasi-experimental study found anticipatory nursing in chronic obstructive pulmonary disease lowered anxiety and depression ...

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...

We currently know that COPD, and specifically emphysema, don’t just happen alongside lung cancer; they increase a person’s ...

A recent study published in the journal of Radiology showed that dynamic chest radiography (DCR) may serve as an effective ...